| Income Statement | 2025-09-30 | |||
|---|---|---|---|---|
| Net sales | 337,926 | |||
| Cost of sales | 171,807 | |||
| Gross profit | 166,119 | |||
| Selling and administrative expense | 140,339 | |||
| Research and development expense | 13,901 | |||
| Operating expenses | 154,240 | |||
| Income from operations | 11,879 | |||
| Interest expense | 7,606 | |||
| Other expense | 0 | |||
| Income before income taxes | 4,273 | |||
| Provision for income taxes | 1,414 | |||
| Net income | 2,859 | |||
| Basic (in dollars per share) | 0.09 | |||
| Basic (in shares) | 30,955,000 | |||
| Diluted (in dollars per share) | 0.09 | |||
| Diluted (in shares) | 31,050,000 | |||
CONMED Corp (CNMD)
CONMED Corp (CNMD)